Market Overview The biomarkers market is experiencing therapeutic emphasis where biomarker-guided drug development, companion diagnostics, and treatment personalization optimize therapeutic efficacy and safety. The biomarkers market is projected to exceed USD 48.6 billion through 2030, with therapeutic emphasis driven by precision medicine focus, efficacy improvement, and patient selection....